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Abstract  
 
The solvent partitioned purified fractions of the  hydro-acetone  root bark extract of the African breadfruit 
(Treculia africana Decne) were evaluated for hypoglycemic activities in normal and diabetic albino rats. Fasting 
blood glucose levels were estimated by the use of a glucometer at pre-determined intervals after oral administration 
of the test extracts/fractions. Results revealed  that the test fractions have only a slight  effect on blood sugar level  
of normal rats. On short term and chronic administration in diabetic rats however, diethyl ether-soluble  (DEF)  and 
the water-soluble (WSF) fractions significantly reduced the fasting blood sugar levels (p<0.05) at differing rates 
when compared with the control group of animals. The diethyl ether soluble fraction  
(10 mg kg-1 dose level) was found to exhibit the highest activity giving 69.4% reduction in blood sugar level (at 240 
hours)  which was  in comparable range with the reference standard  glibenclamide (0.5 mg kg-1) which reduced 
blood sugar levels by 65.8% below the initial baseline values. 
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Introduction 
 
The increasing  incidence of diabetes mellitus worldwide is a major health concern especially since there 
has been a distinct lack of substantial  progress in the development of new, effective, safe and inexpensive therapies 
(Greenfield and Chisholm, 2004). The disease affects well over 15.1 million people in North America, 18.5 million 
in Europe, 12.6 million in Latin America, 6.6 million in former USSR, 5.3 million in Africa and  about 1 million in 
Oceania (Greenfield and Chisholm, 2004). Although different categories of medication such as insulin, 
sulphonylurea, biguanides, thiazolidinediones are presently available to treat diabetes (especially non-insulin 
dependent diabetes, NIDDM), they are however limited in their pharmacokinetic characteristics and  ability to 
manage the disease effectively (Maggs et al., 1998; Misbin et al., 1997 ). In addition, concerns of physicians  over  
side effects observed with current medication  in patients underlines the need for novel approach to treatment. 
Ever since the call by WHO for  a renewed search and discovery of new medicinal agents from natural 
sources (WHO, 1980), increasing number of medicinal plants and herbal remedies are being screened for 
hypoglycemic activity (Anturtikar et al., 1995; Gao, 1989; Ogundipe et al., 2003). Plants with ethno-medicinal  and a 
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nutritive values  have the potential to provide important means or leads for a rational treatment and management  of 
a disease like diabetes, the cure of  which has eluded physicians and health care providers  for centuries.  
Treculia africana Decne (Moraceae), commonly known as African breadfruit is a  plant food native to 
tropical West and parts of East Africa. Ethno-medicinally, it is used as a vermifuge, febrifuge galactogogue and 
laxative (Irvine, 1961). The plant is  also an important component of some ancient anti-diabetic recipe used in 
Western and Middle Belt of Nigeria as our survey among herbalists and  number of patients attending Diabetic 
clinics in the University College Hospital, Ibadan  revealed. . Several workers have evaluated the pods  of T. 
africana for its nutritive properties (Edet et al., 1985; Akubor and  Badifu, 2004), flavonoid,   phenolic and 
polysaccharide content (Oliviera and Santos, 1974; Prista and Alves, 1961; Chukwu et al., 1997). There is however 
no scientific data available regarding the anti-diabetic effect of this plant. 
 In continuation of our investigations into the hypoglycemic activities of African plant foods (Ogundipe et al., 
2003), the objective of the present study is to evaluate the effect of  extracts obtained from  of T. africana root bark   
on the blood sugar levels in both diabetic and non-diabetic  animal models. 
 
Materials and Methods 
Plant Materials 
 
Treculia africana root bark was collected in Mid-July 2004 from the Forest Research Institute of Nigeria 
(FRIN) compound. The plant sample  was subsequently authenticated  by Mr O Odewo and a voucher specimen 
(PCG 038 ) is deposited in the Pharmacognosy herbarium. 
 
Phytochemical Screening/Extration of plant materials 
 
The presence of  the following secondary metabolites in the crude plant  and fractions was evaluated using 
standard procedures: alkaloids, anthraquinones, cardenolides, flavonoids and tannins (Trease and Evans, 1996).   
Air-dried and pulverized root bark (250 g) was macerated in  2 L extraction solvent (acetone: water 4:1) for 7 days. 
The extract  was filtered,  concentrated to low volume and then partitioned with  diethyl-ether. The diethyl ether 
soluble fraction (DEF) was dried to a viscous residue to give a 1.64 % w/w yield. A portion of the diethyl ether 
soluble residue (1 g) was  suspended in 2% w/v methyl cellulose. The dried water-soluble fraction (WSF) was also 
reconstituted into a 2% methyl cellulose suspension. 
 
Thin-Layer Chromatography 
 
Analytical: Silica Gel GF254 (Merck 0.25 mm thick, activated at 100 oC before use 
Solvent system: Toluene : acetone: chloroform (1.8:2:1.2) 
Visualization : UV395, FeCl3 
 
Experimental animals 
 
Adult Wistar albino rats  with an average weight of 100 g used in this study  were obtained from the animal 
house of the Department of Biochemistry, University of Ibadan. The animals were kept  and maintained under 
laboratory conditions of temperature, humidity and light and were allowed free access to standard laboratory diet  
(Ladokun Feeds Ltd, Ibadan) and water ad libitum for a week before the evaluations were carried out.  All 
experimental protocols were in compliance with our institutional ethical committee guidelines as well as 
internationally accepted principles for laboratory animal use and care as found in US guidelines (NIH publication # 
85-23, revised in 1985).  
 
Hypoglycemic activity evaluation  
 
Thirty-two albino rats were fasted overnight but allowed free access to water.  
The animals were divided into “diabetic” rats and “normal” rats. The  “diabetic”  rats  were made diabetic by a 
single intravenous injection of freshly prepared alloxan monohydrate solution  at a dose of 80 mg kg-1. The diabetic 
status of the rats were confirmed by the fasting blood glucose levels (180-350 mg/dl) obtained 48 hours  after 
administration and which is maintained throughout the duration of the experiment.  
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Diabetic  rats were divided into four groups I-IV (n=4) while the normal rats  were also divided into four groups V-
VIII (n = 4) and extracts/ standard reference drugs were administered as follows: 
 
 Diabetic rats 
 
 Group I  - rats in this group received standard drug glibenclamide 0.5 mg kg-1  p.o. Group II – rats in this 
group received  (DEF, 10 mg kg-1) p.o. Group III- rats in this group received (WSF, 10 mg kg-1) p.o. Group IV – rats 
in this group received only the vehicle (2% carboxymethyl cellulose in normal saline) 
 
Normoglycemic rats 
 
Group V-   normal rats in this group received standard drug glibenclamide 0.5 mg kg-1 p.o  Group VI – 
normal  rats in this group received  (DEF, 10 mg kg-1) p.o. Group VII- normal  rats in this group received (WSF, 10 
mg kg-1) p.o. Group VIII – normal rats in this group received only the vehicle (2% carboxymethyl cellulose in 
normal saline. Fasting blood sugar was monitored at 2-hourly intervals after the administration of extracts. 
Subsequent administration of test extacts/reference drug were carried out daily for  another 6 days after the fasting 
blood glucose levels have been determined each day. Blood samples were obtained via the tail blood and glucose 
levels were measured with a glucometer (Reflolux® S), standardized by glucose test strips (code 212). 
Administration of the extracts was stopped on the 7th day after which the animals were observed for an additional 
three (3) days. The last fasting blood  sugar was recorded on the tenth (10th) day of the experiments. 
 
Statistical analysis 
 
Results are expressed as mean ± sem of four determinations. The significance of the differences between 
the means of the test and control animals were established by the student’s t-test and values lower than 0.05 were 
considered to be significant. 
 
Results and Discussion 
 
The results of the present study (Table 1) showed that the fractions obtained from the  hydro-acetone root 
extract have good hypoglycemic effect in diabetic rats  at a very low dose of 10 mg kg-1. The diethyl ether soluble  
fraction (DEF) exhibited a 27.1 % sugar lowering effect within the first 4 hours of administration and had its optimal 
effect (69.4 %) at 240 hours. The standard reference drug (glibenclamide), an oral hypoglycemic agent  at a dose of 
0.5 mg kg-1 gave corresponding figures of 26.4 % and a peak effect of 65.8 % at 240 hours.  
 
Table 1: Effect of T. africana  extracts on fasting blood glucose level of alloxan-induced diabetic rats (Mean ± SEM) aThe values 
in parentheses  represent the percentage of decrease in blood glucose level * Significant difference in glucose level  
when compared with baseline values (p< 0.05) 
Blood glucose mmol/ l  at different hours after treatmenta 
 
 
 
Treatment (p.o) Basal value 2 h 4 h 24 h 72 h 144 h 240 h 
Glibenclamide 
0.5 mg kg-1 
215.75±11.4
9 
 
189.50±12.8
1 
    (12.2) 
*158.75 ± 
10.39 
    (26.4) 
264.25± 
6.00 
 
*80.00 ± 
6.14 
(62.9) 
*96.50±10.5
3 
(55.3) 
*73.75 ± 
5.51 
(65..8) 
Diethylether 
extract DEF 
10 mg kg-1 
193.75± 
4.61 
*147.25 ± 
7.33 
    (24.0) 
*141.25 ± 2.86 
    (27.1) 
*153.25 ± 
5.30 
(20.9) 
*82.00 ± 
1.69 
(57.7) 
*67.75 
±4.30 
(65.0) 
*59.25 
±2.32 
(69.4) 
Water soluble 
extract WSF 
10 mg kg-1 
305.25 ± 
4.38 
249.75 ± 
4.93 
    (18.1) 
271.00 ± 5.86 
    (11.2) 
*233..75 ± 
3.80 
(23.4) 
*221.00 ± 
3.35 
(27.6) 
*74.25±5.90 
(75.7) 
*140.25 ± 
4.11 
(54.1) 
Diabetic control 
(untreated) 
238.67 ± 
4.09 
261.00 ± 
3.46 
309.70 ± 2.05 349.00 ± 
4.02 
378.00 ± 
4.34 
382.00± 
8.72 
380.00 ± 
2.94 
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A progressive reduction in blood sugar level following repeated dosing of  DEF to diabetic rats was  observed.  
Comparing the effect of DEF with glibenclamide, it could be observed that although the lowering effects of the two 
treatments  at 72 h post administration are similar,  there was continued reduction in sugar level by DEF at  
144 h in contrast to the increment in sugar levels exhibited by the reference group of rats.     DEF (10 mg kg-1 dose 
level) therefore showed  a better overall sugar lowering effect  in diabetic rats than glibenclamide (0.5 mg kg-1 ) 
which was chosen  as a standard reference drug in this study as it is well known to be one of the most frequently 
used anti-diabetic drugs (Balazs et al., 2005). 
 
 
Table 2: Effect of T. africana  extracts on fasting blood glucose level of normal  rats (Mean ± SEM) 
 
Blood glucose  mmol/l  at different hours after treatmenta 
 
Treatment (p.o) 
Basal value 2 h 4 h 24 h 72 h 144 h 240 h 
Glibenclamide 
0.5 mg kg-1 
62.00 ± 4.73  
 
44.25± 6.86 
     
41.00 ± 7.25 
    
65.75 ± 
6.69 
 
44.75 ± 
6.17 
 
50.25 ± 7.55  62.50± 4.25 
 
Diethylether 
extract DEF 
10 mg kg-1 
55.00 ± 2.63 *36.75 ± 
5.45 
     
44.75 ± 7.62 
     
60.25 ± 
1.50 
 
53.75 ± 
7.16 
 
42.75 ± 0.46 57.50 ± 7.51 
 
Water soluble 
extract WSF 
10 mg kg-1 
57.25 ± 5.66 47.25 ± 
10.28 
     
50.00 ± 8.66 
     
58.5 ± 
6.47 
 
64.75 ± 
3.12 
63.75 ± 
10.16 
55.25 ± 9.90 
 
Control 
(untreated) 
54.25 ± 4.03 70.00 ± 8.25 71.75 ± 2.47 70.50 ± 
3.38 
60.25 ± 
4.90 
53.75 ± 1.49 44.50 ± 4.41 
 
* Significant difference in glucose level  when compared with baseline values (p< 0.05) 
  
 
 
The water soluble fraction (WSF) of the hydro-acetone extract also showed a strong activity, although a 
cursory observation of Table 1 would give the impression that it is less active than DEF. A careful examination 
shows that WSF may have  some pharmacokinetic advantage over DEF because of the more gradual and controlled 
decreases in blood sugar level exhibited by it,  not only within the first 24 h,  but throughout the experimental period. 
This characteristic may be  particularly useful where reduction of  incidence of unwanted side effects  such as 
hypoglycemia is a major concern.  
It is also  of interest to  note that the significant reduction of the  residual  effect of WSF  on blood sugar 
level after the  termination of its administration  when compared with the residual effects of DEF and the reference 
glibenclamide, both of which continue to exert high hypoglycemic activity 72 hours after the last doses were 
administered. One likely implication of this observation is that the clearance of  WSF  from the system is much 
faster than that of DEF and glibenclamide.   There may also be less tissue accumulation of WSF than that obtained 
for the other fractions/reference drug.. 
In healthy normoglycemic rats, the effects of both DEF and WSF are comparable with glibenclamide which 
produces little or  no significant overall reduction in fasting blood sugar levels on repetitive dosing.(Table 2) 
Phytochemical  and thin layer chromatographic analysis  of the plant material  showed that the crude extracts and 
fractions contain mainly,  flavonoid-related  and anthraquinoid compounds, the characterization of which  are  
subjects of further investigations in our laboratory. Although claims that  flavonoids, like  glibenclamide, are able  to 
regenerate the damaged beta cells in alloxanised diabetic rats (Chakravarthy et al., 1981; Chakravarthy et al., 1982)  
have been severally refuted (Sheehan et al., 1983; Kolb et al., 1982), the  hypoglycemic  effects of T. africana  
extracts in  this study may, in part,  not be unconnected with the flavonoid  and related phenolic component as these 
classes of secondary metabolites  have been shown to be bioactive anti-diabetic principles present in other medicinal 
plants such as Bauhinia forticata Link and Pterocarpus marsupium (de Sousa et al., 2004; Manickam et al., 1997). 
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In conclusion, the data in our present study suggest that Treculia africana, a valued food plant growing abundantly 
in Nigeria, may  have beneficial effects in type-1 diabetes mellitus and may serve as source of  bioactive molecules 
for future generation of anti-diabetic drugs. Comprehensive pharmacological  and phytochemical investigation is 
however required to determine the exact mechanism of action of the hypoglycemic activity of the extracts/fractions 
as well as to  isolate and elucidate the structure of the bioactive molecules responsible for the effects observed 
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